Levetiracetam Biotech 250 mg / 750 mg / 1 000 mg FC tablets
PDF Leaflet Revision Date: 29 July 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Monotherapy and adjunctive therapy for various seizure types in patients with epilepsy.
Dosage (summary)
Starting dose 250 mg twice daily, max 1500 mg twice daily for adults.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy; not recommended during breastfeeding.
Key Drug Interactions
- Methotrexate
- Probenecid
- Macrogol
Contraindications
- Hypersensitivity
- Pregnancy
- Lactation
Common side effects
- Somnolence
- Headache
- Dizziness
- Asthenia
- Nasopharyngitis
Counselling Points
- Monitor for mood changes
- Avoid abrupt discontinuation
- Caution when driving or operating machinery
Serious warnings
- Suicidal ideation
- Acute kidney injury
- Worsening of seizures
Important Disclaimer
The Levetiracetam Biotech 250 mg / 750 mg / 1 000 mg FC tablets professional information leaflet below is the property of Biotech Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
